Accès gratuit
Numéro
Med Sci (Paris)
Volume 18, Numéro 1, Janvier 2002
Page(s) 62 - 69
Section M/S Revues : Articles de Synthèse
DOI http://dx.doi.org/10.1051/medsci/200218162
Publié en ligne 15 janvier 2002
  1. Prusiner SB. Prions. Proc Natl Acad Sci USA 1998; 95: 13363–83.
  2. Laurent M. Les maladies à prion : l’hypothèse de la “protéine seule” et ses conséquences dynamiques. Med Sci 1996; 12 : 774–85.
  3. Caughey B., Interactions between prion protein isoforms: the kiss of death? Trends Biochem Sci 2001; 26 : 235–42.
  4. Riek R, Hornemann S, Wider G, Billeter M, Glockshuber R, Wüthrich K. NMR structure of the mouse prion protein domain PrP (121-231). Nature 1996; 382 : 180–2.
  5. Liemann S, Glockshuber R. Influence of amino acid substitution related to inherited human prion diseases on the thermodynamic stability of the cellular prion protein. Biochemistry 1999; 38 : 3258–67.
  6. Wildegger G, Liemann S, Glockshuber R. Extremely rapid folding of the C-terminal domain of the prion protein without kinetic intermediates. Nat Struct Biol 1999; 6 : 550–3.
  7. Swietnicki W, Morillas M, Chen S, Gambetti P, Surewicz WK. Aggregation and fibrilization of the recombinant human prion protein huPrP90-231. Biochemistry 2000; 39 : 421–31.
  8. Corne JH, Fraser PE;, Lansbury PT. A kinetic model for amyloid formation in the prion diseases: importance of seeding. Proc Natl Acad Sci USA 1993; 90 : 5959–63.
  9. Baskakov IV, Legname G, Prusiner SB, Cohen FE. Folding of prion protein to its native a-helical conformation is under kinetic control. J Biol Chem 2001; 276 : 19687–90.
  10. Morange M. Protéines chaperons. Med Sci 2000; 16 : 630–4.
  11. Liautard JP. Prions and molecular chaperones. Arch Virol 1993; 7 : 227–43.
  12. Edenhofer F, Rieger R, Famulok M, Wendler W, Weiss S, Winnacker EL. Prion protein PrPC interacts with molecular chaperones of the Hsp60 family. J Virol 1996; 70 : 4724–8.
  13. Guerin MC, Bettache S, Aumelas A, Chiche L, Liautard JP. Use of surface plasmon resonance to analyse recombinant prion protein interaction with molecular chaperones. Int J Biochromatogr 2001
  14. Telling GC, Scott M, Mastrianni J, et al. Prion propagation in mice expressing human and chimeric PrP transgenes implicates the interaction of cellular PrP with another protein. Cell 1995; 83 : 79–90.
  15. Raeber AJ, Borchelt DR, Scott M, Prusiner SB. Attempts to convert the cellular prion protein into the scrapie isoform in cell-free Systems.J Virol 1992; 66 : 6155–63.
  16. Caughey BW, Kocisko DA, Raymond GJ, Lansburry PT. Aggregates of scrapie-associated prion protein induce the cell-free conversion of protease-sensitive prion protein to the proteaseresistant state. Curr Biol 1996; 2 : 807–17.
  17. Deburman SK, Raymond GJ, Caughey B, Lindquist S. Chaperone-supervised conversion of prion protein to its protease-resistant form. Proc Natl Acad Sci USA 1997; 94 : 13938–43.
  18. Horiuchi M, Priola SA, Chabry J, Caughey B. Interactions between heterologous forms of prion protein : binding, inhibition of conversion and species barriers. Proc Natl Acad Sci USA 2000; 97 : 5836–41.
  19. Hill AF, Antoniou M, Collinge J. Protease-resistant prion protein produced in vitro lacks detectabble infectivivty. J Gen Virol 1999; 80 : 11–4.
  20. Saborio GP, Permanne B, Soto C. Sensitive detection of pathological prion protein by cyclic amplification of protein misfolding. Nature 2001; 411 : 810–3.